Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.